Apg Asset Management N.V. Alnylam Pharmaceuticals, Inc. Transaction History

Apg Asset Management N.V.

$15.7 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $3.75 Million - $6.46 Million	26,160 Added 38.81%	93,565 $22.7 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $3.79 Million - $5.13 Million	-25,868 Reduced 27.73%	67,405 $10.1 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $648,943 - $842,499	-4,286 Reduced 4.39%	93,273 $17.9 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $1.86 Million - $2.3 Million	-10,889 Reduced 10.04%	97,559 $17.3 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $1.29 Million - $1.48 Million	-6,976 Reduced 6.04%	108,448 $20.6 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $1.78 Million - $2.3 Million	-9,766 Reduced 7.8%	115,424 $23.1 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $18.9 Million - $24.6 Million	101,998 Added 439.8%	125,190 $29.8 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $1.02 Million - $1.71 Million	7,374 Added 46.62%	23,192 $4.74 Million
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $1.05 Million - $1.48 Million	8,721 Added 122.88%	15,818 $2.21 Million
Q1 2022 May 12, 2022	SELL	$127.18 - $173.91 $241,642 - $330,429	-1,900 Reduced 21.12%	7,097 $1.04 Million
Q4 2021 Feb 11, 2022	SELL	$159.56 - $209.29 $555,587 - $728,747	-3,482 Reduced 27.9%	8,997 $1.34 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $373,450 - $457,006	-2,200 Reduced 14.99%	12,479 $2.03 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $28.8 Million - $39.7 Million	-224,256 Reduced 93.86%	14,679 $2.1 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $3.78 Million - $5.24 Million	29,835 Added 14.27%	238,935 $28.7 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $180,028 - $215,208	1,464 Added 0.71%	209,100 $22.2 Million
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $3.97 Million - $5.42 Million	32,723 Added 18.71%	207,636 $25.8 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $2.26 Million - $3.39 Million	21,645 Added 14.12%	174,913 $23.1 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $12 Million - $17.3 Million	128,968 Added 530.73%	153,268 $16.7 Million
Q1 2020 May 14, 2020	SELL	$93.12 - $133.99 $7.47 Million - $10.7 Million	-80,168 Reduced 76.74%	24,300 $2.02 Million
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $588,629 - $981,417	7,900 Added 8.18%	104,468 $10.7 Million
Q3 2019 Nov 08, 2019	BUY	$70.9 - $87.82 $4.52 Million - $5.6 Million	63,768 Added 194.41%	96,568 $7.12 Million
Q2 2019 Aug 13, 2019	BUY	$65.86 - $92.79 $559,810 - $788,715	8,500 Added 34.98%	32,800 $2.09 Million
Q4 2018 Feb 13, 2019	BUY	$62.67 - $88.33 $62,670 - $88,330	1,000 Added 4.29%	24,300 $1.55 Million
Q2 2018 Aug 13, 2018	BUY	$88.31 - $107.8 $1.06 Million - $1.29 Million	12,000 Added 106.19%	23,300 $1.97 Million
Q1 2018 May 14, 2018	BUY	$115.92 - $148.54 $173,880 - $222,810	1,500 Added 15.31%	11,300 $1.09 Million
Q4 2017 Jan 24, 2018	BUY	$114.49 - $139.98 $1.12 Million - $1.37 Million	9,800	9,800 $1.04 Million

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.04 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.09 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.34 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.28 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.21 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account